Key Insights

Highlights

Success Rate

78% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 39/100

Termination Rate

20.0%

2 terminated out of 10 trials

Success Rate

77.8%

-8.7% vs benchmark

Late-Stage Pipeline

60%

6 trials in Phase 3/4

Results Transparency

57%

4 of 7 completed with results

Key Signals

4 with results78% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (1)
P 1 (1)
P 2 (1)
P 3 (5)
P 4 (1)

Trial Status

Completed7
Terminated2
Withdrawn1

Trial Success Rate

77.8%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (10)

Research Network

Activity Timeline